Obesity has been associated with worse prognosis for certain cancers, although data are conflicting for some types of cancer [1] . Comorbid diabetes mellitus also has been associated with reduced survival among patients with certain common cancers (e.g. breast, colon-rectum and endometrium) [2] but there is potential confounding with obesity (the major risk factor for diabetes). Studies of prognosis should use population-based cancer registries, but comorbidity has not been included in database of the US National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program. SEER registries could incorporate data from many hospitals, however, because the American College of Surgeons' Commission on Cancer [3] requires that each hospital cancer registry code (using ICD-9-CM) up to six comorbid conditions and/or treatment complications from the hospital record. ICD-9-CM includes codes for obesity and diabetes, but these conditions must be adequately recorded in hospital records in order to be useful for studies of prognosis.
Information on recording of comorbid diabetes and obesity in any hospital admission 12 months before (or around the time of) cancer diagnosis has been abstracted from hospital records for two samples of patients' aged 20+ years, ascertained from the Connecticut SEER registry. Sample 1 included 539 patients randomly selected from all diagnoses in 2002 [4] . Sample 2 included 985 patients coded as Spanish origin or 'Asian'-American 'race' who were diagnosed with a reportable cancer in 2002-2003 [5] ; these minority groups have a relatively high lifetime risk of diabetes.
The prevalence of recorded comorbid diabetes was high (especially in sample 2) ( Table 1) , even though the extent of screening for undiagnosed diabetes is uncertain. Severity of diabetes was available for coding (using a scheme for surgery patients) [6] for 91% of diabetic patients. Excluding unknowns, the proportion with any diabetes medication ( Table 1 ) was slightly higher than that reported from the National Health Interview Survey of adults in 2002 (80.4%) and 2003 (80.3%) [7] .
Obesity was recorded only for $20% of patients with body mass index (BMI) of 30+ kg/m 2 and 60% with BMI 40+ kg/m 2 ( using a hospital discharge diagnosis of obesity to detect associations with cancer risk [8] . The rising prevalence of (and high health risks associated with) severe/extreme obesity [9] support the potential utility of comorbid 'obesity' recorded in hospitals. However, recognition and/or recording of obesity was poor ( Table 2 ). The need for oncologists to recognize and treat overweight (after cancer therapy) also has been recognized [10] .
In conclusion, comorbidity codes from hospitals [3, 11] should be incorporated into SEER registries (and this has begun in the Connecticut registry) but obtaining data on diabetes treatment and all degrees of obesity would require accessing hospital records, for large-scale population-based studies of prognosis. Cancer clinical trials have obtained history of diabetes, use of diabetes medications and BMI from medical charts [12] , but patients without severe comorbidity may tend to be overselected. 
